"Antigens, CD34" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glycoproteins found on immature hematopoietic cells and endothelial cells. They are the only molecules to date whose expression within the blood system is restricted to a small number of progenitor cells in the bone marrow.
| Descriptor ID |
D018952
|
| MeSH Number(s) |
D23.050.301.264.035.134 D23.101.100.110.134
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antigens, CD34".
Below are MeSH descriptors whose meaning is more specific than "Antigens, CD34".
This graph shows the total number of publications written about "Antigens, CD34" by people in this website by year, and whether "Antigens, CD34" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 1 | 1 | 2 |
| 1998 | 0 | 2 | 2 |
| 1999 | 3 | 2 | 5 |
| 2000 | 0 | 4 | 4 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2004 | 0 | 4 | 4 |
| 2005 | 0 | 5 | 5 |
| 2006 | 1 | 5 | 6 |
| 2007 | 0 | 4 | 4 |
| 2008 | 0 | 1 | 1 |
| 2009 | 2 | 1 | 3 |
| 2010 | 0 | 1 | 1 |
| 2011 | 2 | 5 | 7 |
| 2012 | 0 | 5 | 5 |
| 2013 | 0 | 1 | 1 |
| 2014 | 3 | 2 | 5 |
| 2015 | 1 | 1 | 2 |
| 2016 | 1 | 3 | 4 |
| 2017 | 0 | 3 | 3 |
| 2018 | 0 | 4 | 4 |
| 2019 | 0 | 2 | 2 |
| 2020 | 0 | 2 | 2 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antigens, CD34" by people in Profiles.
-
Optimal infused CD34+ cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation. Blood Cancer J. 2024 10 31; 14(1):189.
-
Thoracic solitary fibrous tumors with small cell features: A clinicopathological and immunohistochemical analysis of 5 cases. Ann Diagn Pathol. 2024 Dec; 73:152353.
-
Evaluating the efficiency and safety of large-volume leukapheresis using the Spectra Optia continuous mononuclear cell collection protocol for peripheral blood stem cell collection from healthy donors: A retrospective study. Transfusion. 2023 11; 63(11):2120-2130.
-
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial. Nat Med. 2023 04; 29(4):869-879.
-
Allogeneic CD34+ selected hematopoietic stem cell boost following CAR T-cell therapy in a patient with prolonged cytopenia and active infection. Pediatr Blood Cancer. 2023 03; 70(3):e30166.
-
Case of recurrent superficial CD34-positive fibroblastic tumor. J Cutan Pathol. 2023 Jun; 50(6):477-480.
-
Radiation Therapy Can Be Safely Incorporated into Pretransplantation Treatment Regimens for Patients with Multiple Myeloma. Transplant Cell Ther. 2023 01; 29(1):37.e1-37.e7.
-
Red blood cell depletion in small-volume bone marrow processing using manipulation with third-party red blood cells: A comparison of the performance of the COBE spectra and the spectra Optia systems. Transfusion. 2022 09; 62(9):1829-1838.
-
Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometry. Cytometry B Clin Cytom. 2022 07; 102(4):283-291.
-
Superficial CD34-positive fibroblastic tumor (SCPFT): A review of pathological and clinical features. Ann Diagn Pathol. 2022 Jun; 58:151937.